Studies show that 16–40% of pediatric patients experience residual paralysis when anesthesia is managed without objective monitoring (Faulk et al., 2024; Domenech et al, 2019; and Kotake, 2013).

Objective electromyography (EMG) monitoring significantly reduces residual block vs. clinical signs or accerelomyography(AMG).

Proactive decision support to enhance patient safety

EMG-based quantitative TOF monitoring enables safe and accurate neuromuscular block management for your most delicate patients.

Optimized NMBA dosing

Supporting you in your choice of neuromuscular blocking agents (NMBA).

Reversal strategy with precision

Guiding you in choice of reversal agent type and reversal dose for your specific case.

Adequate recovery

Helping you to choose if spontaneous recovery is an option or not, and if adequate recovery of breathing muscles is obtained.

Safe extubation

Assisting you in finding the correct timing for safe tracheal extubation.
 

Image
TetraGraph and TetraSens Pediatric
One solution for your pediatric needs

TetraGraph and TetraSens Pediatric provide safety you can trust, ensuring full recovery before extubation to protect your most vulnerable patients.

  • Easy and intuitive sensor application
  • Gentle on delicate skin
  • One-size flexible design to fit different patient sizes
  • Trusted EMG technology
Contact us to explore TetraSens Pediatric
Image
The solution for accurate neuromuscular block management

TetraGraph and TetraSens Pediatric

  • Pediatric-specific and skin-safe design: Regulatory-cleared separately and specifically for infants ≥1 month, with a low-profile, flexible electrode array gentle on delicate skin.
  • Proven signal strength feedback: EMG technology delivers strong, consistent signals—
    even in children <2 years or with tucked arms where AMG fails. Individualized signal strength confirms correct sensor placement at the start and ensures accurate readings throughout the case.
  • Seamless workflow: Quick and easy setup, no calibration required, and continuous TOF data without interrupting clinical flow.
  • Smarter dosing decisions: Intuitive TetraGraph Level-of-Block Gauge provides
    real-time feedback to guide precise NMBA and reversal dosing, optimizing safety and minimizing unnecessary drug use.
Download TetraGraph for pediatrics flyer
Explore quantitative monitoring for pediatric patients

Get started today!

Contact us to request a complimentary demo, and explore how TetraGraph and TetraSens Pediatric can help you enhance pediatric patient care.

One size fits all
Flexibility in size, simplicity in use

TetraSens Pediatric can easily be placed on either hand or foot, helping to improve the workflow in your OR setting. It’s approved to be used on pediatric patients from 28 days after born.

Get additional insights
Four reasons for quantitative monitoring in pediatrics

Read this blog to learn four reasons why you should be using quantitative neuromuscular monitoring for pediatric patients.

Read blog
Elevating pediatric anesthesia: Expert roundtable

Watch this roundtable discussion to hear a panel of experts sharing their experiences and insights on the challenges faced in pediatric anesthesia

Watch video
References
  1. Faulk, Debra J., et al. “The Incidence of Residual Neuromuscular Block in Pediatrics: A Prospective, Pragmatic, Multi-institutional Cohort Study.” Cureus, vol. 16, no. 3, 2024, e56408.
  2. Motamed, C. “Intraoperative Monitoring of Neuromuscular Blockade.” Life, vol. 13, no. 5, 2023, p. 1184.
  3. Carvalho, H., et al. “Forty Years of Neuromuscular Monitoring and Postoperative Residual -Curarisation: A Meta-analysis.” British Journal of Anaesthesia, vol. 125, no. 4, 2020, pp. 466–482.
  4. Owusu-Bediako, Kwaku, et al. “Feasibility of Intraoperative Quantitative Neuromuscular Blockade Monitoring in Children Using Electromyography.” Saudi Journal of Anaesthesia, vol. 16, no. 4, 2022, pp. 412–418.
en sv de